Anti Osteoporosis Therapy and Fracture Healing Market is Expected to Surpass US$ 12 Bn by the End of 2021

Market

According to the National Osteoporosis Foundation, there has been a substantial increase in osteoporosis incidence among postmenopausal women due to calcium deficiency. This is driving the market for anti-osteoporosis therapy and fracture healing.

Future Market Insights, Dubai: FMI has projected the anti-osteoporosis therapy and fracture healing-market to record a CAGR of 3% through 2030. The demand for anti-osteoporosis therapy and fracture healing treatment is anticipated to continue surging due to the rising demand for non-invasive therapeutics.

Osteoporosis is a chronic and a life-threatening disease in which the microstructure of bones is altered due to reduction in bone mass and bone density. This condition leads to increased bone brittleness and risk of bone fractures and cracks. Thus, osteoporosis is considered life threatening due to severe injury and associated pain. The significant reduction in the bone mass density leads to changes in microstructure of the bones resulting in increased threat of bone cracks and bone fractures. According to the International Osteoporosis Foundation (IOF), osteoporosis is also known as a silent disease because many people do not know they have osteoporosis until they have a fist fracture. Based on an IOF report, each year osteoporosis causes more than 8.9 million fractures and bone cracks across the globe. Furthermore, it is indicated that nearly 200 million women all over the world are being affected by osteoporosis every year.

Key players are adopting merger and acquisition strategies for increasing their presence across the globe,” says the FMI analyst.

Anti-Osteoporosis Therapy And Fracture Healing treatment Market – Important Highlights

  • Bisphosphonates will remain the preferred drug type due to the growing adaptation to target-specific treatments
  • The oral route of administration is expected to remain most preferred
  • Profit from hospital pharmacy is projected to grow by 2X by 2030 compared to 2019.
  • The U.S. is leading the global market for anti-osteoporosis treatment and fracture healing, with revenues estimated to exceed US$ 6.3 billion by 2030

Request a report sample to gain comprehensive market insights at

https://www.futuremarketinsights.com/reports/sample/rep-gb-1008

Anti-Osteoporosis Therapy And Fracture Healing Treatment Market – Drivers

  • Increase in geriatric population, who are at high risk of osteoporosis, is driving the market
  • The increasing pace of drug approval and commercialization are enabling growth
  • Increasing investment in innovation and new product launches are expected to boost the market

 Anti-Osteoporosis Therapy and Fracture Healing Treatment Market – Restraints

  • Significantly less understanding of osteoporosis and its treatment choices in GCC countries is hindering the growth of the market.
  • Poor economic conditions and healthcare infrastructure might hinder the adoption of anti-osteoporosis therapy and fracture healing treatment across some countries

COVID-19 Impact on Anti-Osteoporosis Therapy And Fracture Healing treatment Market

During this time there has been a disruption in the supply and demand chain which has caused an impact on the revenue of the Anti-Osteoporosis Therapy And Fracture Healing treatment in a negative way. However, this is estimated to be a temporary effect and the market is expected to have a turnaround. The pandemic has led to a decrease in the patient’s flow in the hospitals, and doctor chambers. This has caused a reduction in the number of surgeries and that in turn has affected the Anti-Osteoporosis Therapy And Fracture Healing treatment market.

Get Access to Research Methodology Prepared by Experts>>> https://www.futuremarketinsights.com/ask-question/rep-gb-1008

Competitive Landscape

Key companies are aiming at strategic collaboration. The Anti-osteoporosis treatment and fracture healing industry is a relatively consolidated market with fewer than 10 market players comprising more than 50% of the overall revenue.

Some of the leading companies operating in the market are Eli Lilly and Company, Pfizer Inc., Amgen Inc., Merck and Company, Inc., Novartis International AG, F. Hoffmann La Roche Ltd.

About the Study

The study offers readers a comprehensive assessment of the Anti-Osteoporosis Therapy And Fracture Healing treatment market. Global, regional, and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights based on drug class (Bisphosphonates, Calcitonin, Estrogen or Hormone Replacement Therapy), route of administration (oral, injectable), distribution channel (Hospital Pharmacies, Retail Pharmacies, Online sales), and across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

Ask For Country-Specific Data https://www.futuremarketinsights.com/ask-country-specific/rep-gb-1008

Explore FMI’s Coverage of the healthcare Industry

Rapid Infuser Market: Get insights on the rapid infuser market through FMI’s report covering detailed quantitative and qualitative analysis for the projection period 2020-2030.

Medical face shield market: FMI’s exhaustive study on the medical face shield market covers the latest trends, innovations, key players, and popular strategies for the period 2020-2030.

laryngoscopes market: Obtain detailed analysis on the Laryngoscopes market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2020-2030.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:

Future Market Insights,

1602-6 Jumeirah Bay X2 Tower,

Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Website: https://www.futuremarketinsights.com/

Report: https://www.futuremarketinsights.com/reports/anti-osteoporosis-therapy-and-fracture-healing-market

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.